Prescription Drug Overdose: Data-Driven Prevention Initiative
CDC released RFA-CE16-1606, Prescription Drug Overdose: Data-Driven Prevention Initiative to advance and evaluate state-level prevention of opioid misuse, abuse, and overdose.
CDC’s Injury Center intends to commit up to $21,000,000 total funding over the 3-year project period with a maximum of $750,000 per award per year. This funding is available at two different levels to support planning and data activities alone, or additional development of an overdose prevention program.
The Planning and Data component will fund cooperative agreements to improve data collection and analysis to support the development of a prescription opioid overdose prevention strategy. The additional Prevention in Action component will support the implementation of a comprehensive opioid overdose prevention program that impacts behavior and reduces the negative health consequence of the prescription opioid overdose epidemic.
Desired outcomes of related prevention programs include:
- Decreased rates of opioid prescribing
- Decreased number of emergency department visits related to opioid misuse
- Decreased rates and number of opioid-related overdose deaths
States can apply for the Planning and Data component alone, or for both components. States currently funded under the Prescription Drug Overdose: Prevention for States are not eligible to receive funding under this FOA.
Applications due: May 27, 2016.
The funding opportunity announcement can be found at www.grants.gov or on the Injury Center funding opportunities announcement page at www.cdc.gov/injury/
fundedprograms/foa. Note that amendments to the announcement focus and application dates are possible. Please check for updates on grants.gov.
Learn more about CDC’s prescription opioid overdose prevention activities atwww.cdc.gov/drugoverdose.